|
GB201609473D0
|
|
MT-45 Immunodetection
|
|
GB201600812D0
|
|
Chemiluminescence detector
|
|
WO2016102939A1
|
|
Method for predicting response to oesophageal cancer therapy
|
|
WO2016097711A1
|
|
Improvements relating to biochip storage wells
|
|
GB201519142D0
|
|
Method
|
|
GB201518993D0
|
|
Improvements relating to analysis of biochips
|
|
GB201517731D0
|
|
Methods for cardiovascular conditions
|
|
GB201511725D0
|
|
Assay
|
|
GB201509564D0
|
|
Method and kit for detecting bacterial infection
|
|
GB201506152D0
|
|
Method
|
|
WO2015155513A1
|
|
Diagnosis of cancer by detecting dimeric il-18
|
|
GB201503425D0
|
|
Prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention
|
|
GB201502226D0
|
|
AH-7921 detection
|
|
GB201501597D0
|
|
Thrombomodulin
|
|
GB201501415D0
|
|
Method
|
|
GB201419634D0
|
|
Lung cancer sub-typing method
|
|
GB201418233D0
|
|
Microfluidic chip
|
|
GB201417447D0
|
|
Improved immunoassay for pyrrolidinophenones
|
|
GB201417384D0
|
|
Detection of polymyxins
|
|
GB201416733D0
|
|
Detection of indazole synthetic cannabinoids
|
